This study is looking at how different eye imaging techniques, like Swept-Source (SS) OCT Angiography, Spectral-Domain (SD) OCT Angiography, Fundus Imaging, and Axial Length Measurement, can help doctors better understand and track retinal vascular diseases. These diseases include diabetic retinopathy, retinal vein occlusion, and high blood pressure affecting the eyes. The goal is to find better ways to see how these conditions change over time, whether they get worse or better with treatment. You might be able to join if you are between 18 and 99 years old and have one of these conditions, or if you are a healthy control. The study aims to follow participants for 5 years to see how the imaging results correlate with disease changes. The current status of the study is unclear.

Study design

This is an interventional study planning to enroll 1050 participants, including both healthy individuals and those with retinal vascular disease.

What's involved

You would undergo non-invasive, minimal risk eye imaging procedures using FDA-approved devices. The study will also review and collect existing clinical imaging data.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, correlation of imaging, will be measured at 5 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.